The **FAIL verdict is correct and robust**. Coverage counting and the precision failure reproduce independently. The screen nevertheless overstates policy feasibility and leaves several SPEC requirements unresolved.

Read-only review completed using the permitted inputs. No prohibited files were opened; predictor fields were used only for presence/absence checks.

The coverage findings are:

| Counting rule | Covered endpoints | Maximum components per endpoint |
|---|---:|---:|
| Selected model per component, both axes | 250 | 1 |
| Selected model, format only | 250 | 1 |
| Selected model, medium only | 250 | 1 |
| Any retained model, both axes | 250 | 1 |

The reconstructed 724-component partition exactly matches the retained-set audit. Only **ACH-000178, Hs 766T**, supplies paired observations among the 729 retained models. Its component maps to `SIDP00129` through confirmed identifier routes. Thus axis choice and any-model counting do **not** improve coverage.

Across the entire atlas paired file, there are 3,000 rows and seven distinct models: `ACH-000048`, `ACH-000108`, `ACH-000178`, `ACH-001418`, `ACH-002958`, `ACH-003040`, and `ACH-003052`. These are seven models, **not seven verified independent donors**. Format coverage spans six models; medium coverage spans four.

All 250 endpoints tie at one retained component, so **ABI2 is correctly first under ascending-symbol tie-breaking**. That verifies the coverage-ranking rule, but does not establish that ABI2 satisfies the preceding qualification requirements.

I found **one high, seven medium, and two low issues; no critical issues**:

1. **High — Policy feasibility passes without documented confirmation-assay availability.**  
   The code equates an existing eligible screen with the ability to receive the proposed future confirmation assay. It then sets `policy_pass = bool(n and K >= 1)`. Neither establishes the required assay availability, endpoint-specific action, or usable predictors for that action. The reported `feasibility_pass: true` is unsupported. `K=ceil(0.10×1)=1` and the one-unit estimated budget are arithmetically correct; they do not establish feasibility. [Code, lines 169–181](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/src/sgen013_screen.py:169)

2. **Medium — The policy direction is registered, but its stated scientific support overreaches.**  
   Prioritizing larger `|L|` is an explicit, outcome-blind proposal. However, the rationale describes a historical Lock-S result as a “source definition” and transfers a relationship across genes to prioritization across components for one gene. That component-level implication is unestablished. The code also makes policy passage independent of whether the rationale is justified. Register this as a proposed hypothesis pending justification, or supply an assay-specific rationale based on source definitions. [Code, lines 172–181](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/src/sgen013_screen.py:172)

3. **Medium — Coverage presence substitutes for registration of a specific L/B measurement.**  
   The coverage loop pools format and medium contrasts, but the SPEC requires paired-format L. For Hs 766T, the format row measures Dome versus Plastic with medium held fixed; the medium row measures OPAC versus RPMI/FBS with format held fixed. Both contain genuine model-specific measurements, but they are different predictors with different reference baselines. The screen never fixes which contrast, signed/absolute definition, and baseline supply L/B. Restricting coverage to format leaves the same decisive `n=1`, so this does not rescue feasibility. [Code, lines 109–127](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/src/sgen013_screen.py:109)

   The donor limitation needs careful wording: the canonical ModelID and confirmed component mapping support a provisional model-to-component join. They do **not** resolve the atlas’s original donor provenance or establish independent source sampling. Conversely, these rows are not merely gene-level summaries copied across models.

4. **Medium — Endpoint ranking occurs without the required qualification step.**  
   The implementation ranks every covered gene before assessing endpoint-specific identity, compatibility, and policy requirements. ABI2’s metadata explicitly records `Tier-A_outcome_informed_selection_exclusion` and marks both historical eligibility fields false. Those historical exclusions need not automatically prohibit a separately registered target study, but their applicability must be adjudicated. Merely printing the flags does not do that. The candidate universe also includes an explicitly unadjudicated alias. ABI2 should currently be described as the **coverage-ranked diagnostic candidate**, rather than a fully qualified selected endpoint. [Code, lines 129–159](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/src/sgen013_screen.py:129)

5. **Medium — Provenance verification does not pin the actual coverage inputs.**  
   The report pins three historical files, but omits the retained-set audit and the actual v4 paired, genes, and manifest files. Checking upstream files named by an unpinned manifest does not verify the consumed v4 outputs. Missing upstream files are silently skipped, and the upstream hash checks use assertions that disappear under optimized Python execution. The three explicit historical pins match the supplied files; the remaining provenance claim is incomplete. [Code, lines 20–24 and 67–80](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/src/sgen013_screen.py:67)

6. **Medium — Canonical ScreenID selection and the reviewable cohort record are missing.**  
   Ascending ModelID selection is implemented correctly. Ascending eligible ScreenID selection is absent. This matters beyond a theoretical possibility: retained selected model `ACH-000614` has two eligible ScreenIDs in the audit. For the sole covered model, the target screen is unambiguous—`SC-000178.AV01`—so present coverage is unaffected. The output also omits the selected component/model/screen mapping and explicit coverage exclusions, including the 723 selected components without paired data. [Code, lines 103–107](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/src/sgen013_screen.py:103)

7. **Medium — The bundle cap does not establish a valid dependence adjustment.**  
   The two ABI2 source pairs share the Dome/RPMI-FBS screen. Counting distinct ordered screen pairs therefore does not count independent source units. Applying Fisher-z to `min(n, number_of_pairs)` is an unvalidated dependence heuristic. Here the cap remains one and cannot alter FAIL; a broader cohort would require a justified treatment of shared screens and source sampling. [Code, lines 164–167](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/src/sgen013_screen.py:164)

8. **Medium — The failure/resource statement is correct in direction but incomplete.**  
   More independent matched paired-format L/B measurements are necessary. They are insufficient without resolving the endpoint bridge, source dependence, and confirmation-policy requirements. The alternative “an endpoint with broader paired coverage” is exhausted within the current retained atlas: all 250 endpoints have exactly one component. The statement should identify an additional measurement resource and retain those other prerequisites explicitly. [Output, lines 106–108](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/sgen013/screen_v1.json:106)

9. **Low — Undefined precision is reported opaquely.**  
   Serializing the internal infinity sentinel as JSON `null` avoids a nonstandard numeric value, but produces the uninformative failure text `MDR None / bundle-capped None`. Report “undefined: insufficient degrees of freedom,” alongside `n`, covariate count, degrees of freedom, and the calculation. [Code, lines 189–203](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/src/sgen013_screen.py:189)

10. **Low — Required terminal and gate dispositions are absent from the output.**  
    The report records FAIL but does not explicitly record “scientifically unresolved; this branch infeasible,” stopping outcome work pending a qualifying resource, or the required preservation/nonpromotion of C-gate statuses. It makes no false transport-success claim, but leaves these SPEC instructions undocumented. [SPEC, lines 99–113](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/generations/sgen013/SPEC.md:99)

The **precision arithmetic itself is correct**:

\[
\mathrm{MDR}=\tanh\!\left(\frac{1.959964+0.841621}{\sqrt{n-3-p}}\right).
\]

The code counts baseline plus lineage indicators, excluding the intercept: \(p=1+(J-1)\). With one component and one lineage, \(p=1\), giving \(n-3-p=-3\); the calculation is undefined and must fail. Capping by two source pairs leaves \(n=1\). Under the same approximation, even with only the baseline covariate and independent source information, **at least 367 components** are required for MDR ≤0.146.

I found **no numerical predictor-value use in selection**, no target-outcome access in the inspected code, and no borrowing of the nominal cohort size to pass precision. The explicit statement that **Lock-S is spent** is appropriate, although ABI2’s additional selection-history flag still needs treatment.

Finally, the [atlas manifest inputs list](/Users/bmarti44/github/bufferright/research/cancer-dependency-rsi/atlas/v4/manifest.json:41) names only v3 genes, exclusions, paired observations, and manifest. It identifies no additional independent measurement resource. Its paired-file digest matches the supplied v4 paired file, and its note states that measurements were inherited unchanged. **No broader matched L/B coverage is documented by those permitted provenance records.**

SGEN013_SCORE: 80